MiR-379-5p aggravates experimental autoimmune uveitis in mice via the regulation of SEMA3A

References

• Hsu YR, Chang SW, Lin YC, et al. Expression of microRNAs in the eyes of lewis rats with experimental autoimmune anterior uveitis. Mediators Inflam. 2015;2015:457835.
   PubMed Web of Science ®Google Scholar
• Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162.
   PubMed Web of Science ®Google Scholar
• Rao NA. Uveitis in developing countries. Ind J Ophthalmol. 2013;61:253–254.
   PubMed Web of Science ®Google Scholar
• Klaska IP, Muckersie E, Martin-Granados C, et al. Lipopolysaccharide-primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms. Immunology. 2017;150:364–377.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
   PubMed Web of Science ®Google Scholar
• Shi L, Guo H, Li Z, et al. Adenovirus-mediated down-regulation of miR-21-5p alleviates experimental autoimmune uveoretinitis in mice. Int Immunopharmacol. 2019;74:105698.
   PubMed Web of Science ®Google Scholar
• Hsu YR, Chang SW, Lin YC, et al. MicroRNA-146a alleviates experimental autoimmune anterior uveitis in the eyes of lewis rats. Mediators Inflamm. 2017;2017:9601349.
   Google Scholar
• Sun Y, Guo D. 2018. Regulatory role of rno-miR-30b-5p in IL-10 and toll-like receptor 4 expressions of T lymphocytes in experimental autoimmune uveitis in vitro. Mediators Inflamm. 2018;2574067.
   Google Scholar
• Li J, Xue J, Wang D, et al. Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells. Metallomics: integrated Biometal Science. 2019;11(2):483–495.
   PubMed Web of Science ®Google Scholar
• Baulina N, Kulakova O, Kiselev I, et al. Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission. J Neuroimmunol. 2018;317:67–76.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Nakashima T, Taniguchi M, et al. Osteoprotection by semaphorin 3A. Nature. 2012;485:69–74.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Nakashima T, Yoshimura N, et al. Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metab. 2019;29:627–637.e625.
   PubMed Web of Science ®Google Scholar
• Eixarch H, Gutiérrez-Franco A, Montalban X, et al. Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis. Trends Mol Med. 2013;19(3):157–164.
   PubMed Web of Science ®Google Scholar
• Liu LN, Li XM, Ye DQ, et al. Emerging role of semaphorin-3A in autoimmune diseases. Inflammopharmacology. 2018;26:655–665.
   PubMed Web of Science ®Google Scholar
• Binamé F, Pham-Van LD, Spenlé C, et al. Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination. EMBO Mol Med. 2019;11:e10378.
   PubMed Web of Science ®Google Scholar
• Hong BK, You S, Yoo SA, et al. MicroRNA-143 and -145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis. Exp Mol Med. 2017;49:e363.
   PubMed Web of Science ®Google Scholar
• Agarwal RK, Silver PB, Caspi RR. Rodent models of experimental autoimmune uveitis. Methods Molecul Biol (Clifton, N.J.). 2012;900:443–469.
   PubMedGoogle Scholar
• Walter FR, Gilpin TE, Herbath M, et al. A novel in vitro mouse model to study mycobacterium tuberculosis dissemination across brain vessels: a combination granuloma and blood-brain barrier mouse model. Curr Protocols Immunol. 2020;130:e101.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Niu T, Cheng L, Wang H, et al. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis. J Neuroinflammation. 2019;16(1):278.
   PubMed Web of Science ®Google Scholar
• Bing SJ, Shemesh I, Chong WP, et al. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells. J Autoimmunity. 2019;100:52–61.
   PubMed Web of Science ®Google Scholar
• Chen X, Su W, Wan T, et al. Sodium butyrate regulates Th17/Treg cell balance to ameliorate uveitis via the Nrf2/HO-1 pathway. Biochem Pharmacol. 2017;142:111–119.
   PubMed Web of Science ®Google Scholar
• Dang Y, Wang X, Hao Y, et al. MicroRNA-379-5p is associate with biochemical premature ovarian insufficiency through PARP1 and XRCC6. Cell Death Dis. 2018;9:106.
   PubMed Web of Science ®Google Scholar
• Lv X, Wang M, Qiang J, et al. Circular RNA circ-PITX1 promotes the progression of glioblastoma by acting as a competing endogenous RNA to regulate miR-379-5p/MAP3K2 axis. Eur J Pharmacol. 2019;863:172643.
   PubMed Web of Science ®Google Scholar
• Wu D, Niu X, Tao J, et al. MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncol Rep. 2017;37:3502–3508.
   PubMed Web of Science ®Google Scholar
• Zheng J, He Q, Tang H, et al. miR-455-5p Overexpression Reduces Rat Lung Alveolar Type II Cell Proliferation by Downregulating STRA6. Anat Rec. 2019;302(11):2062–2069.
   Google Scholar
• Alique M, Bodega G. MicroRNA-126 regulates Hypoxia-Inducible Factor-1alpha which inhibited migration, proliferation, and angiogenesis in replicative endothelial senescence. Sci Rep. 2019;9:7381.
   Google Scholar
• Zhang F, Duan C, Yin S, et al. MicroRNA-379-5p/YBX1 axis regulates cellular EMT to suppress migration and invasion of nasopharyngeal carcinoma cells. Cancer Manage Res. 2020;12:4335–4346.
   PubMed Web of Science ®Google Scholar
• Ji W, Diao YL, Qiu YR, et al. LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis. Cell Death Dis. 2020;11:16.
   PubMed Web of Science ®Google Scholar
• Chen JS, Li HS, Huang JQ, et al. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Cancer Lett. 2016;375:73–83.
   PubMed Web of Science ®Google Scholar
• Hashida N, Ohguro N, Nishida K. Expression analysis of cytokine and chemokine genes during the natural course of murine experimental autoimmune uveoretinitis. ISRN Inflamm. 2012;2012:471617.
   PubMedGoogle Scholar
• Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007;13:711–718.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang P, Zhou H, et al. Diminished frequency and function of CD4 + CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008;49(8):3475–3482.
   PubMed Web of Science ®Google Scholar
• Vadasz Z, Toubi E. Semaphorin3A: A potential therapeutic tool in immune-mediated diseases. European Journal of Rheumatology. 2018;5:58–61.
   PubMed Web of Science ®Google Scholar
• Catalano A. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. JI. 2010;185(10):6373–6383.
   Google Scholar
• Liu LN, Wang P, Zou YF, et al. Semaphorin-3A, semaphorin-7A gene single nucleotide polymorphisms, and systemic lupus erythematosus susceptibility. Autoimmunity. 2019;52(4):161–167.
   PubMed Web of Science ®Google Scholar
• Vadasz Z, Peri R, Eiza N, et al. The Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity. J Immunol Res. 2015;2015:1–6.
   Web of Science ®Google Scholar
• Zhao PY, Wang YQ, Liu XH, et al. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis. J Ethnopharmacol. 2018;217:36–48.
   PubMed Web of Science ®Google Scholar
• Liao HT, Lin YF, Chou CT, et al. Semaphorin 3A in ankylosing spondylitis. J Microbiol, Immunol Infect. 2019;52(1):151–157.
   PubMedGoogle Scholar